Company / Operating Income per Share
TG Therapeutics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.79
FY2025
5-year range
-$2.45 / $0.79
FY2021-FY2025
Trend
+185.8%
vs FY2024
Sector context
#40 of 201
Health Care
What the data says
TG Therapeutics, Inc.'s operating income per share of $0.79 is higher than 80% of companies in the Health Care sector (FY2025). Operating Income per Share has increased for 5 consecutive years, from $-2.50 in FY2020 to $0.79 in FY2025.
Based on SEC 10-K filings.
0.79 in FY2025. Top quartile in the Health Care sector.
Improved from $0.14 to $0.79 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+102.8% above sector average
Key checks
Key Insights
- TG Therapeutics, Inc.'s operating income per share has grown for 5 consecutive years.
- In FY2025, operating income per share increased 185.8% year-over-year.
- Ranks #40 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.79 | +185.8% |
| FY2024 | $0.28 | +96.5% |
| FY2023 | $0.14 | +109.2% |
| FY2022 | -$1.52 | +37.9% |
| FY2021 | -$2.45 | +1.9% |
| FY2020 | -$2.50 | -76.7% |
| FY2019 | -$1.42 | +40.6% |
| FY2018 | -$2.38 | -24.7% |
| FY2017 | -$1.91 | -18.8% |
| FY2016 | -$1.61 | -16.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026